Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: Relationship to egf receptors

International Journal of Cancer

Volumn 46, Issue 3, 1990, Pages 416-420

  Reubi, J C ^a   Waser, B ^a   Foekens, J A ^b   Klijn, J G M ^b   Lamberts, S W J ^c   Laissue, J ^d  

^a NOVARTIS PHARMA AG   (Switzerland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RADIOISOTOPE; SOMATOSTATIN RECEPTOR;

ARTICLE; AUTORADIOGRAPHY; BREAST CANCER; FEMALE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AUTORADIOGRAPHY; BREAST NEOPLASMS; COMPARATIVE STUDY; FALSE NEGATIVE REACTIONS; HUMAN; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; OCTREOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, SOMATOSTATIN;

EID: 0025127942     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910460315     Document Type: Article

References (30)

1. Epidermal growth factor receptor and oestrogen receptors in the non‐malignant part of the cancerous breast
2. 6]‐luteinizing‐hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
3. Prognostic value of receptors for insulin‐like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer
4. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase
5. Somatostatin receptors in human growth hormone and prolactin‐secreting pituitary adenomas
6. Synthesis of somatostatin by breast‐cancer cells and their inhibition by exogenous somatostatin and sandostatin
7. Correlative study on neuro‐endocrine differentiation and presence of somatostatin receptors in breast carcinomas
8. Distribution of somatostatin receptors in the human brain: an autoradiographic study
9. Hormone‐producing gastrointestinal tumors contain high density of somatostatin receptors
10. Visualization of somatostatin receptors and correlation with immunoreactive GH and PRL in human pituitary adenomas. Evidence for different tumor subclasses
11. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinoma
12. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation‐dependent relationship in glial tumors
13. High density of somatostatin receptors in pituitary tumors from acromegalic patients
14. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system
15. Somatostatin receptors in human endocrine tumors
16. Distinct topographical localisation of two somatostatin receptor subpopulations in the human cortex
17. EGF receptors in human breast cancer on viable and necrotic tumour cells
18. Relationship between somatostatin, EGF‐and steroid‐hormone‐receptors in breast cancer
19. Somatostatin receptors are present in small‐cell but not in non‐small‐cell primary lung carcinomas: relationship to EGF‐receptors
20. Epidermal‐growth‐factor receptor status as predictor of early recurrence of and death from breast cancer
21. Epidermal‐growth‐factor receptors and oestrogen receptors in human breast cancer
22. Antiproliferative effects of somatostatin and the somatostatin analogue SMS 201‐995 on three human breast‐cancer cell lines
23. Oncological applications of somatostatin analogues
24. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast‐cancer cells
25. Evaluation of receptors for somatostatin in various tumors using different analogs
26. Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH‐RH and somatostatin
27. Effect of the long‐acting somatostatin analog SMS 201‐995 (Sandostatin) in advanced breast cancer
28. Inhibition of growth of human breast carcinoma in vivo by somatostatin analog SMS 201–995: treatment of nude mouse xenografts
29. Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria